Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

EAG Acquires PTRL West and PTRL Europe

Published: Thursday, April 12, 2012
Last Updated: Thursday, April 12, 2012
Bookmark and Share
EAG adds new division to serve high-end analytical testing needs of the chemical and pesticide industry.

Evans Analytical Group, Inc. (EAG) has announced that it has acquired PTRL West, Inc. (Hercules, CA) and PTRL Europe GmbH (Ulm, Germany).

PTRL West and PTRL Europe will continue to operate under their current names and locations as divisions of EAG. Financial terms of the transaction were not disclosed.

PTRL has created a world-wide business serving the regulatory testing needs of the leading international agrochemical companies.

PTRL provides specialized services in Analytical Chemistry and Residue Analysis, Environmental Fate and Metabolism to assist in the required regulatory testing to bring new pesticides to market and to perform testing required for re-registrations of compounds.

PTRL serves the regulatory requirements of the U.S. EPA, U.S. FDA, EU, REACH, OECD and JMAFF governmental agencies.

The work conducted at the PTRL facilities is in compliance with Good Laboratory Practices (GLP) for the Agrochemical industry and complements our GLP work for the pharmaceutical industry conducted within our EAG Life Sciences Division.

With a continuing commitment to scientific expertise, accuracy of chemical analysis, investment in advanced instrumentation and technologies, and building long-term business partnerships with customers, PTRL has established itself as the premier laboratory for executing challenging analytical work.

For over 20-years, customers from the U.S, Europe and Japan have relied on PTRL as a trusted partner in the complex, regulated process of bringing new pesticides to market.

Harry Davoody, CEO of EAG states "Both PTRL and EAG value our customer relationships first and foremost. The acquisition of PTRL was very compelling to EAG and fits into EAG's overall growth strategy in offering a broader range of high-end analytical services for new and existing customers of EAG. EAG's different divisional strengths complement each other with their best-in-class subject matter expertise which is highly valued by our specialized customers."

Dr. Luis Ruzo, co-founder and Head of PTRL West, affirmed that "PTRL is pleased to become part of an organization as well-regarded as EAG. This merger is very important to PTRL, providing us with additional resources from a solid long-standing company which supports our efforts to continue to grow our labs and our capabilities for our valued customers."

Dr. Thomas Class, co-founder and Head of PTRL Europe, noted "PTRL carefully selected EAG knowing that PTRL and its team will be part of EAG's future growth engine beyond EAG's existing markets. EAG recognized the potential in the agrochemical segment and is very committed to further investing in our business going forward."

Virginia M. Turezyn, SVP of Business Development and Strategy, comments "The agrochemical market sector has been on our radar for some time and we were pleased to have the best-in-class management and team at PTRL to serve as the cornerstone for EAG's entry into this industry."

Neal McCarthy, Managing Director of Fairmount Partners, who assisted PTRL and EAG in this transaction commented "With the acquisition of PTRL, EAG has added the finest agrochemical lab in North America and Europe, and with Dr. Luis Ruzo and Dr. Thomas Class and the other PTRL scientists, EAG adds world class experts in the field of agrochemicals, to its impressive roster of scientific talent."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Researchers Find Key Player in Diabetic Kidney Disease Through Power of Metabolomics
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Early Antiretroviral Therapy Prevents Non-AIDS Outcomes in HIV-infected People
NIH-supported findings illustrate manifold benefit of therapy.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
First Made-in-Singapore Cancer Drug Enters Clinical Testing
The drug prevents cancer progression and paves the way for new advancements in cancer therapeutics.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!